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DObjective: To examine the early results of the David V valve-sparing aortic root replacement procedure in
expanded, higher risk clinical scenarios with appropriately selected patients.
Methods: From 2005 to 2011, 150 David V valve-sparing aortic root replacements were performed within
Emory Healthcare. A total of 78 patients (expanded group) had undergone the David V in expanded, difficult
clinical settings such as emergent type A dissection (n ¼ 29), grade 3þ or greater aortic insufficiency (AI)
(n ¼ 53), or reoperative cardiac surgery (n ¼ 14). These patients were evaluated and compared with a group
of 72 patients (traditional group) with less than grade 3þAI who underwent a David V in a traditional, elective
setting. The mean follow-up was 19 months (range, 1–72), and the follow-up data were 88% complete.
Results: There were 3 operative deaths (2.2%), all occurring in the expanded group. The overall patient survival
at 6 years was 95%. Three patients required aortic valve replacement: two for severe AI and one for fungal
endocarditis. Both groups had concomitant cusp repairs performed in conjunction with the David V (traditional,
n ¼ 10; and expanded, n ¼ 16; P ¼ .27). At follow-up, freedom from moderate AI was 93%, and the freedom
from aortic valve replacement was 98%. No significant difference was observed in the freedom from moderate
AI between the expanded and traditional groups (91% vs 95%, respectively; P ¼ .16).
Conclusions: In selected patients possessing appropriate aortic cusp anatomy, the David V can be safely
and effectively performed for the expanded indications of aortic dissection, severe AI, and reoperative cardiac
surgery with low operative risk. Valve function has remained excellent in the short term, providing evidence of
durability and a low rate of valve-related complications. (J Thorac Cardiovasc Surg 2012;143:879-84)Valve-sparing aortic root replacement has become the ideal
operation for young patients with aortic root pathology and
normal aortic valve cusps. Two techniques for this proce-
durewere pioneered byDavid and Feindel1 (reimplantation)
and Sarsam and Yacoub2 (remodeling) and have been
adopted worldwide by cardiac surgeons during the past 2
decades. Originally developed for the treatment of patients
with Marfan syndrome with aortic root aneurysms and nor-
mal aortic cusps, the David reimplantation procedure has
been modified since its initial description,3-8 and its use
has gradually been expanded to other clinical scenarios.
As the procedure has evolved, experts have expressed
their concerns regarding the feasibility of performing
a valve-sparing root replacement in patients with severee Clinical Research Unit,a Division of Cardiothoracic Surgery, Joseph B
ehead Department of Surgery, Emory University School ofMedicine, Atlanta,
nd Rollins School of Public Health,b Emory University School of Medicine,
ta, Ga.
ures: Authors have nothing to disclose with regard to commercial support.
the 37th Annual Meeting of The Western Thoracic Surgical Association,
ado Springs, Colorado, June 22–25, 2011.
d for publication June 20, 2011; revisions received Dec 25, 2011; accepted for
cation Jan 16, 2012; available ahead of print Feb 13, 2012.
for reprints: Edward P. Chen, MD, Division of Cardiothoracic Surgery,
y Clinic, 1365 Clifton Road, Suite A2236, Atlanta, GA 30322 (E-mail:
n@emory.edu).
23/$36.00
ht  2012 by The American Association for Thoracic Surgery
016/j.jtcvs.2012.01.048
The Journal of Thoracic and Caaortic insufficiency (AI) or in higher risk settings such as re-
operative surgery or acute type A dissection.9-12
In a previous report, we described our experience of per-
forming the David V reimplantation procedure (David V)
in 37 patients in the setting of acute type A dissection, reo-
perative cardiac surgery, or severe AI.13 These patients had
perioperative outcomes equivalent to those of a group of
patients who had undergone a Bentall procedure in similar
scenarios. The present report expands on our previous
efforts by comparing the short-term results of a larger
cohort of patients who underwent a David V in these higher
risk scenarios with those of an elective cohort of patients
with minimal AI who underwent a David Vas their primary
cardiac operation. The goal of the present analysis was to
provide additional safety and durability data to evaluate
the expanded use of the David V procedure. Broader appli-
cation of this procedure for the treatment of complex root
pathology in a wide variety of expanded, higher risk clinical
settings will potentially enable more patients to avoid valve
replacement and its inherent pitfalls.METHODS
The present study was conducted with approval of the institutional
review board of Emory University in compliancewith the Health Insurance
Portability and Accountability Act regulations and the Declaration of
Helsinki. The institutional review board waived the need for individual
patient consent. From January 2005 through June 2011, 150 patientsrdiovascular Surgery c Volume 143, Number 4 879
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AI ¼ aortic insufficiency
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reimplantation technique at Emory University-affiliated hospitals. These
patients were divided into 2 groups according to the indications (traditional
or expanded, higher risk clinical settings for which a valve-sparing root
replacement procedure has been described).9-12 Of the 150 patients, 78
(expanded group) underwent a David V in the following situations:
reoperative cardiac surgery (n ¼ 14), emergent acute type A aortic
dissection (n ¼ 29), or greater than moderate AI ( grade 3þ; n ¼ 53).
These patients were compared with a traditional, elective cohort of 72
patients (traditional group) who underwent a primary elective David V
procedure for aortic root aneurysms with moderate AI or less ( grade
2þ). All elective cases were evaluated with preoperative transesophageal
echocardiography to evaluate the aortic root complex. The aortic valve
cusps were carefully inspected for any signs of degeneration such as free
margin thickening, calcification, and prolapse. The presence and degree
of AI was noted, as well as the eccentricity of any regurgitant jets. The
final decision on whether to proceed with a David V procedure was
determined by direct inspection of the cusps intraoperatively after
opening the root.
Surgical Technique
All procedures were performed through a median sternotomy using
cardiopulmonary bypass. Patients undergoing isolated aortic root replace-
ment received right atrial and central aortic cannulation. In patients requir-
ing total proximal aortic replacement and arch reconstruction under
hypothermic circulatory arrest, the right axillary artery was cannulated
as previously described.14,15
Once the aorta was transected, the aortic cusps were carefully inspected
for calcification, perforations, stress fenestrations, free margin elongation,
and prolapse. After the decision was made to proceed with the David V, the
root was circumferentially dissected down to the nadir of the aortic annulus.
All abnormal sinus tissue was excised, leaving a 4- to 5-mm rim of aortic
tissue along the annulus. Coronary buttons were dissected free and mobi-
lized. The diameter of the aortic graft prosthesis was determined using
a modification of the original David-Feindel formula: graft dia-
meter ¼ [2 3 (Hcusp 3 2/3)]þ6–8 mm.1 A ruler was used to measure the
height of the cusp from the hinge point at the nadir of the annulus to the
free margin edge at the nodule of Arantius. For both bicuspid and tricuspid
valves, this manner of graft sizing allowed for a graft larger than the ideal
sinotubular junction and annulus, which was subsequently plicated down
at the top and bottom positions to create the neosinus segments.
All aortic prostheses used in the present series were woven polyester
Gelweave (Vascutek; Terumo, Ann Arbor, Mich) grafts. Most prostheses
were tailored straight tube grafts; however, the Gelweave Valsalva graft
was used in certain cases, depending on surgeon experience and preference.
In the cases with a tailored graft, the annulus was measured with a transpar-
ent valve sizer (Medtronic Freestyle; Medtronic, Minneapolis, Minn). If
annular dilation was present, interrupted 3-0 polypropylene pleating su-
tures were used to plicate the annular end to the diameter of the valve sizer.
Next, three 3-0 braided polyester horizontal mattress sutures were placed
through the left ventricular outflow tract 2 mm below the nadir of the
annulus and passed through the tailored end of the graft. Before seating,
the commissural stitches were brought through the inside of the graft.
The anchoring sutures were then tied to secure the graft to the annulus.
Next, the commissural sutures were pulled up vertically with outward
radial traction, and the cusps were assessed for optimal coaptation. Once
the ideal position of each commissure was determined, the sutures were
passed through the graft and tied on the outside. The valve was then880 The Journal of Thoracic and Cardiovascular Surgreimplanted into the graft using 3 running 4-0 polyprolene sutures starting
at the nadir of each cusp. After valve reimplantation, the coronary buttons
were reimplanted using 5-0 polypropylene sutures. The graft was then pli-
cated between the tops of the commissures with interrupted 4-0 pleating
stitches to create a neosinotubular junction and 3 neosinuses. The neoroot
was inspected, and any necessary cusp repair procedures were performed at
that time. Cusp repair procedures were performed with 6-0 polytetrafluoro-
ethylene (Gore-Tex suture, WL Gore & Associates, Flagstaff, Ariz) and
included leaflet plication, free margin reinforcement, and commissural
annuloplasty. When valve competence was satisfactory, the distal anasto-
mosis was completed.
Echocardiography
Intraoperative transesophageal echocardiography was used for all
patients. Transthoracic echocardiograms were obtained for 87% of the
patients before discharge. The patients were followed up prospectively,
and annual surveillance echocardiographic examinations were scheduled
for all patients. The grade of AI was interpreted using color flow mapping
and continuous wave Doppler echocardiography. AI was reported accord-
ing to a semiquantitative scale as 0 (grade 0), trace (grade 0.5), mild
(grade 1), moderate (grade 2), moderate-severe (grade 3), and severe (grade
4). The more severe grade of AI was recorded in cases in which the regur-
gitant jet was interpreted as in between 2 grades (eg, mild to moderate was
recorded as moderate).
Statistical Analysis
The pre-, peri-, and postoperative variables were descriptively com-
pared between the 2 risk groups (traditional and expanded). Bivariate
analyses were performed using 2-sample t tests and chi-square tests to
determine whether the means and proportions, respectively, were different
between groups. Kaplan-Meier analysis was performed to estimate the sur-
vival distributions across the risk groups. The product-limit estimate for
1-, 3-, and 6-year survival was calculated using the death dates for each pa-
tient provided by the Social Security Death Index.
RESULTS
The preoperative characteristics are listed in Table 1. The
mean patient age was 45  13 years and did not differ
between the 2 groups. A significantly greater incidence of
male gender, hypertension, and preoperative renal failure
was present in the expanded group. The traditional group
contained a greater percentage of patients with Marfan
syndrome (traditional, 19%; expanded, 6.5%; P ¼ .03).
The mean aortic root diameter was larger in the expanded
group (expanded, 5.6 cm; traditional, 5.2 cm; P< .001).
Also, 65% of the expanded group had greater than moder-
ate AI on the preoperative echocardiogram, including 35
patients (45%) with severe AI. In contrast, 82% of the
traditional group had less than moderate AI.
The cardiopulmonary bypass, crossclamp, and circula-
tory arrest times were significantly longer in the expanded
group (P < .05). This can be explained by the greater
incidence of concomitant procedures performed in the ex-
panded group. The additional procedures included hemi-
and total arch reconstruction under moderate hypothermic
circulatory arrest, coronary artery bypass, and mitral valve
repair procedures. Both cohorts contained patients who
required cusp repairs in addition to the David V, with a
slightly greater incidence in the expanded group (Table 2).ery c April 2012
TABLE 1. Preoperative characteristics
Characteristic
Traditional
(n ¼ 72)
Expanded
(n ¼ 78) P value
Age (y) 45.3  14 45.8  12 .74
Male gender 52 (72) 71 (91) .01*
BMI (kg/m2) 28  6 29  6 .33
History of CVA 2 (3) 4 (5) .48
NYHA class III/IV 4 (6) 13 (17) .30
Diabetes mellitus 8 (11) 3 (4) .16
Hypertension 39 (54) 56 (72) .04*
Renal failure 2 (3) 16 (21) <.01*
COPD 5 (7) 11 (14) .14
Aortic root diameter (cm) 5.2  0.4 5.6  0.8 <.001*
Ejection fraction (%) 59  7 54  8 <.001*
Bicuspid aortic valve 13 (18) 10 (13) .17
Marfan syndrome 14 (19) 5 (6) .03*
Previous cardio-aortic surgery 0 14 (18) <.001*
Emergent type A dissection 0 29 (37) <.001*
Preoperative AI <.001*
Zero 13 (18) 3 (4)
Trace 16 (22) 3 (4)
Mild 30 (42) 13 (17)
Moderate 13 (18) 8 (10)
Moderate to severe 0 16 (21)
Severe 0 35 (45)
Data presented as mean standard deviation or numbers, with percentages in paren-
theses. BMI, Body mass index; CVA, cerebral vascular accident; NYHA, New York
Heart Association; COPD, chronic obstructive pulmonary disease; AI, aortic insuffi-
ciency. *Statistically significant.
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was 2%. There were 3 operative deaths, all in the ex-
panded group. Two of the deaths occurred early in the se-
ries in patients who presented with acute type A aortic
dissection and grade 4þAI. One patient died of a massive
perioperative stroke and 1 of right ventricular failure sec-
ondary to cocaine-induced cardiomyopathy. The third
mortality was an elective case in a patient withTABLE 2. Perioperative data
Variable
Traditional
(n ¼ 72)
Expanded
(n ¼ 78) P value
CPB 223  44 256  60 <.01*
Crossclamp 198  39 216  45 .01*
HCA 26  13 35  18 .01*
Hemiarch replacement 33 (46) 42 (54) .21
Total arch replacement 5 (7) 8 (10) .44
Cusp repairs 10 (14) 16 (21) .27
Mitral repairs 3 (4) 4 (5) .60
CABG 4 (6) 12 (15) .17
Ventilation time (hr) 12.3  12 42.3  101 .01*
ICU LOS (d) 2.1  2 3.3  5 .04*
Hospital LOS (d) 6.7  4 8.4  7 .07
Data presented as mean  standard deviation or numbers, with percentages in
parentheses. CPB, Cardiopulmonary bypass; HCA, hypothermic circulatory arrest;
CABG, coronary artery bypass grafting; ICU, intensive care unit; LOS, length of
stay. *Statistically significant.
The Journal of Thoracic and Capreoperative 3þAI who died on postoperative day 3 sec-
ondary to acute liver failure. There were 4 other
nonaortic-related late deaths, all in the expanded group.
For the entire series, the survival at 6 years of follow-up
was 95%. Figure 1 shows the Kaplan-Meier survival
curves for the expanded and traditional groups.
An additional 7 patients not included in the present
analysis of 150 patients underwent a David V procedure
but had excessive AI on release of the crossclamp. These
7 patients, who were in the first 20% of our cases, under-
went conversion intraoperatively to a Bentall procedure
(4 in the expanded group and 3 in the traditional group),
with no mortality. Of the 150 patients, 9 required mediasti-
nal reexploration for bleeding (expanded, 5; traditional, 4).
Postoperative ventilator requirements were significantly
longer in the expanded group (expanded, 42  101 hours
vs traditional, 12  12 hours; P ¼ .01). This contributed
to longer intensive care unit and overall hospital lengths
of stay for the expanded group (Table 2).
All patients left the operating room with less than
grade 2þAI. Of the 2 groups, 61 (84%) of the traditional
and 67 (89%) of the expanded group had annual surveil-
lance follow-up echocardiograms. The mean length of
follow-up was 19 months (range, 1–72). At data analysis,
surveillance echocardiograms had been obtained for 29%
of patients in the postoperative period alone, in 52% of
patients at longer than 1 year, and in 26% of patients at
longer than 3 years.
A total of 9 patients (traditional, 3; expanded, 6) who
developed grade 2þ or greater AI in the follow-up period.
Of the 3 traditional patients, 1 developed fungal endocardi-
tis after 13 months and required a homograft root, ascend-
ing, hemiarch replacement. The remaining 2 patients had
grade 2þAI on the echocardiogram at 3 and 6 years postop-
eratively. In the expanded group, 2 patients developed grade
4þ AI within 13 months of their original operation andFIGURE 1. Survival of traditional and expanded patients after David V
valve-sparing aortic root replacement. At follow-up, survival was 100%
in the traditional group and 91% in the expanded group.
rdiovascular Surgery c Volume 143, Number 4 881
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patients developed grade 3þAI at 3 years of follow-up; 1 of
these patients underwent a reoperative valve repair, which
reduced the AI to grade 1þ, and the other was treated
medically. Of the remaining 2 patients with grade 2þAI,
1 patient died of nonaortic-related causes, and 1 was lost
to follow-up. The short-term freedom from moderate AI
was 95% in the traditional group and 91% in the expanded
group (P ¼ .16). The freedom from aortic valve-related
reoperation was 99% in the traditional and 96% in the
expanded groups (Figure 2). Overall, the freedom from
aortic valve replacement for the series was 98%.
DISCUSSION
After the initial report by David and Feindel1 describing
the use of the reimplantation procedure in 10 patients,
surgeons began to adopt the operation to treat patients
with aortic root aneurysms and normal aortic valve cusps
throughout the 1990s. In the past 10 years, surgeons have
begun to modify the procedure and to use it in situations
that were originally considered unconventional. In a previ-
ous study, we demonstrated the feasibility of performing
a David V in certain higher risk subgroups with excellent
short-term results.13 In the present report, we sought to pro-
vide more data to support expanding the indications for per-
forming the David V in these higher risk scenarios.
In the present investigation, we reviewed the outcomes of
150 patients who underwent a David V reimplantation pro-
cedure. To evaluate the safety and efficacy of the David V in
the higher risk population, we used our conventional David
V cohort of patients as internal controls. Both groups were
composed of young patients with a mean age of 45 years.
The traditional group had a significantly larger percentage
of patients with Marfan syndrome (traditional, 19%; ex-
panded, 6%; P ¼ .03). Most of these patients had root an-
eurysms, minimal AI, and normal cusps and were ideal
patients for a David V. The expanded cohort contained
a more complex group of patients with a greater incidenceFIGURE 2. Freedom from aortic valve-related reoperation after David V
valve-sparing aortic root replacement. At follow-up, freedom from reinter-
vention was 99% in the traditional group and 96% in the expanded group.
882 The Journal of Thoracic and Cardiovascular Surgof preoperative renal failure. These patients required more
concomitant procedures, in addition to the David V, and
had longer cardiopulmonary bypass, crossclamp, and circu-
latory arrest times. These factors undoubtedly contributed
to their longer ventilator requirements and intensive care
unit and hospital lengths of stay.
As specified by the design of the study, the patients in the
expanded group included all those with greater than moder-
ate AI preoperatively. Severe AI has been considered by
some surgeons to be a relative contraindication to a valve-
sparing procedure, especially if it is chronic AI with an
eccentric jet.12,16 Severe AI is not a risk factor for
operative death, but concern exists that in the setting of
long-standing severe AI, the cusps could be intrinsically
damaged, causing sclerosis, elongation of the free margin,
and prolapse. These cases often require repair to 1 or
more cusps, in addition to root reconstruction, and, there-
fore, carry the correspondent risk of failure in both the short
and long term.12 Because of these concerns, patients with
severe AI were placed in the expanded group.
In a recent series examining the results of valve-sparing
procedures (remodeling or reimplantation) performed in
the setting of severe AI, 5 of 6 patients who required subse-
quent aortic valve replacement had severe AI preopera-
tively. The freedom from greater than mild AI at 5 years
was 88% in patients with less than severe preoperative AI
compared with 50% in patients with severe preoperative
AI.17 In our series, 35 patients (23%) had severe AI preop-
eratively, 7 of whom had bicuspid valves and 12, type A
dissection. In this subgroup, a single patient with a trileaflet
aortic valve developed recurrent severe AI requiring valve
replacement. Freedom from moderate AI was 100% for
the remaining 34 patients. Excellent long-term valve func-
tion has been documented by others who have performed
David Vs in the setting of preoperative severe AI.18,19
Because of its technical complexity and reliance on
proper 3-dimensional reconstruction of the aortic root, the
David V reimplantation procedure has been described as
unforgiving with respect to small technical errors.7 This
has given caution to many surgeons who have entertained
the idea of performing a valve-sparing procedure in the
setting of emergent repair of an acute type A aortic dissec-
tion.22 The surgical treatment of acute type A aortic dissec-
tion still carries a 24% in-hospital mortality rate according
to the most recent International Registry of Acute Aortic
Dissection report.20 However, patients presenting with
type A dissection are often young with normal cusps. If
the dissection involves the root, or the patient has a concom-
itant root aneurysm, valve-sparing root replacement might
be an ideal operation. In the present study, 29 patients un-
derwent a David V procedure in the setting of emergent
type A repair. All 29 patients underwent arch reconstruc-
tion, with 3 patients undergoing total arch replacement.
There were 2 operative deaths, for a mortality rate ofery c April 2012
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phy, valve function was preserved, with a 93% freedom
from moderate AI. These data add to the work of others
who have reported excellent long-term valve function
and low mortality with valve-sparing procedures in the
setting of acute type A aortic dissection.18,21,22 It must be
emphasized that survival remains a primary goal in the
surgical treatment of type A aortic dissection. Therefore,
we share the opinions of others who have recommended
that the reimplantation procedure should be performed in
the setting of acute type A dissection only after gaining
sufficient experience with the operation in the elective
setting.21
The third subgroup addressed in the present study
was patients undergoing reoperative cardiac surgery. The
David V reimplantation technique requires an extensive
circumferential dissection of the aortic root down to a level
below the nadir of each sinus. Only by reaching this level
can the aortic annulus be appropriately anchored inside
the graft (preventing future annular dilation), which repre-
sents a fundamental step of the procedure. In the reoperative
setting, circumferential dissection of the root down to the
level of the nadir of the sinus segments can be challenging,
depending on the severity of the adhesions. The pulmonary
artery, right ventricular outflow tract, right atrium, and left
atrium can all be tightly adhered to the sinuses and are at
risk of inadvertent injury that can go unrecognized until
crossclamp removal. Because of these concerns, a prefer-
ence for performing the remodeling procedure in lieu of
reimplantation in the reoperative setting has been ex-
pressed.10 In our series, 14 patients (18%) in the expanded
group were undergoing reoperation. Of these 14 cases, 8
were previous aortic cases, including 5 previous type A dis-
section repairs. Two patients presented with a previous Ross
procedure with dilated autografts. In both of these patients,
the aneurysmal sinus tissue was excised, and the valve was
successfully reimplanted inside a tailored graft. In this sub-
group of 14 patients, 1 patient developed severe AI and re-
quired aortic valve replacement and 2 patients developed
mild AI. The remainder had 0 or trace AI during follow-up.
Both groups contained patients who underwent cusp re-
pair as a part of their reimplantation procedure. Although
originally developed for patients with normal cusps, the
expanded use of valve-sparing procedures during the past
decade has largely been driven by the ability of surgeons
to repair imperfect, prolapsed cusps with techniques such
as cusp plication, free margin reinforcement, and triangular
resection.16,23,24 Many of the large valve-sparing series
reported contain a significant number of patients who
required cusp repairs.18,23,25 However, there have been
reports that the need for cusp repair is associated with the
development of postoperative AI and reoperation for
valve replacement.25,26 This raises the inevitable question
of whether these patients should have undergone a BentallThe Journal of Thoracic and Caprocedure as their primary operation. In the present
series, we performed cusp repairs in 26 patients (17%;
traditional, 10; expanded, 16), with acceptable outcomes.
There was 1 death and 1 patient who required subsequent
aortic valve replacement. The freedom from moderate
AI in the remaining patients was 92%. This cohort of
patients will be closely monitored for the development of
significant AI and the need for aortic valve reintervention.
The limitations of the present study included the inherent
selection bias from the study design and ongoing follow-up.
Valve-sparing procedures are complex operations that were
originally designed for a limited number of patients with
aortic root aneurysms and normal aortic valve cusps. In
attempting to expand the indications in which the David
V reimplantation procedure can be performed, wewere sub-
ject to inherent selection bias when offering this operation
to patients, especially those in the expanded group. During
the period covered by the present retrospective review, the
patients in the expanded group represented approximately
10% of all our reoperative aortic procedures, 10% of all
aortic dissections, and 15% of all our aortic root replace-
ments. These patients were carefully selected to be a candi-
date for the David V only if their aortic cusp anatomy was
believed to be appropriate for successful and durable repair.
We captured follow-up echocardiograms for 88% of the
patients in the present study. Follow-up echocardiographic
surveillance is continuous and ongoing, and fewer cases
were done earlier in the study period. At data analysis, a
significant percentage (29%) of these studies had only
been obtained in the early postoperative period. Most
patients had follow-up for longer than 12 months, and
26% have had follow-up for longer than 3 years. In addi-
tion, data regarding left ventricular size was not collected
as a part of the present report. Ongoing prospective assess-
ment of valve function continues, and additional durability
data are being gathered. Owing to the follow-up period in
the present study, the longer term success of the valve
repairs has not been as thoroughly assessed as the short-
term valve function.
In conclusion, the data presented in the present report
support the expanded use of the David V valve reimplanta-
tion procedure for aortic root reconstruction in the setting of
emergent type A dissection, reoperative cardiac surgery,
and severe AI in experienced hands. No significant differ-
ences were found when comparing the outcomes between
the traditional and expanded groups. Operative mortality
was low, and valve function in early follow-up remained
durable. Valve-sparing aortic root replacement is an optimal
therapy for aortic root pathology in suitable patients. It
offers the patient the potential prospect of definitive treat-
ment while avoiding the lifelong burden of anticoagulation
or the inevitability of a second valve operation. The follow-
up data reported in the present study were relatively short
compared with the valve function for commerciallyrdiovascular Surgery c Volume 143, Number 4 883
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Davailable prosthetic aortic valves. Therefore, long-term
surveillance is mandatory and will ultimately determine
whether patients undergoing these procedures in these
expanded clinical settings are truly receiving the optimal
therapy.
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